{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:42:13Z","timestamp":1789512133343,"version":"build-2803163510"},"reference-count":30,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Purine nucleoside phosphorylase (PNP) deficiency has been recently introduced in the newborn screening program in Tuscany. In order to improve the PNP screening efficiency, we developed a 2nd tier test to quantify PNP primary markers deoxyguanosine (dGuo) and deoxyinosine (dIno).<\/jats:p>\n                  <jats:p>Dried blood spots (DBS) samples were extracted with 200 \u03bcL of methanol and 100 \u03bcL of water (by two steps). Internal standards were added at a final concentration of 10 \u03bcmol\/L. After extraction, samples were analysed by LC-MS\/MS. The chromatographic run was performed in gradient mode by using a Synergi Fusion column.<\/jats:p>\n                  <jats:p>The assay was linear over a concentration range of 0.05\u201350 \u03bcmol\/L (R<\/jats:p>\n                  <jats:p>The LC-MS\/MS method can reliably measure dIno and dGuo in DBS for the diagnosis of PNP. Validation data confirm the present method is characterised by good reproducibility, accuracy and imprecision for the quantitation of dIno and dGuo. The assay also appears suitable for use in monitoring treatment of PNP patients.<\/jats:p>","DOI":"10.1515\/cclm-2015-0436","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T13:00:57Z","timestamp":1444827657000},"source":"Crossref","is-referenced-by-count":7,"title":["Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry"],"prefix":"10.1515","volume":"54","author":[{"given":"Giancarlo","family":"la Marca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giocaliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Malvagia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Villanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Funghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ombrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Della","family":"Bona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Forni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementina","family":"Canessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Resti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Azzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1172\/JCI109058","article-title":"Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency","author":"Cohen","year":"1978","journal-title":"J Clin Invest"},{"key":"ref271","first-page":"127","article-title":"la Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect : a reliable and inexpensive method using tandem mass spectrometry","author":"Azzari","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref201","article-title":"novel mutation in purine nucleoside phosphorylase in a child with normal uric acid levels","author":"Saud","year":"2009","journal-title":"Clin Biochem"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12026-012-8380-9","article-title":"nucleoside phosphorylase deficiency presenting as severe combined immune deficiency","author":"Somech","year":"2013","journal-title":"Immunol Res"},{"key":"ref171","doi-asserted-by":"crossref","DOI":"10.1016\/S0031-3955(05)70270-4","article-title":"immunodeficiencies","author":"Elder","year":"2000","journal-title":"cell Pediatr Clin Am"},{"key":"ref161","first-page":"3","article-title":"ML nucleoside phosphorylase deficiency","author":"Markert","year":"1991","journal-title":"Rev"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1080\/15257770.2011.630852","article-title":"nucleoside phosphorylase deficiency a mutation update","volume":"30","author":"Walker","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clinbiochem.2007.11.007","article-title":"Novel mutations of NP in two patients with purine nucleoside phosphorylase deficiency","author":"Parvaneh","year":"2008","journal-title":"Clin Biochem"},{"key":"ref311","first-page":"45","article-title":"International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use ICH harmonized tripartite guideline : Guideline for Good Clinical","volume":"47","year":"2001","journal-title":"Practice J Postgrad Med"},{"key":"ref221","first-page":"125","article-title":"Primary immunodeficiencies","author":"Notarangelo","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref01","first-page":"3","article-title":"ML nucleoside phosphorylase deficiency","author":"Markert","year":"1991","journal-title":"Rev"},{"key":"ref141","first-page":"2015","article-title":"la Expanded newborn screening by mass spectrometry new tests future perspectives","author":"Ombrone","journal-title":"Mass Spectrom Rev"},{"key":"ref81","first-page":"480","article-title":"Combined immune deficiencies due to purine enzyme defects In ER HD JA editors Immunologic disorders in infants and children th ed Philadelphia PA","author":"Hershfield","year":"2004"},{"key":"ref111","first-page":"127","article-title":"la Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect : a reliable and inexpensive method using tandem mass spectrometry","author":"Azzari","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref41","article-title":"novel mutation in purine nucleoside phosphorylase in a child with normal uric acid levels","author":"Saud","year":"2009","journal-title":"Clin Biochem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12026-012-8380-9","article-title":"nucleoside phosphorylase deficiency presenting as severe combined immune deficiency","author":"Somech","year":"2013","journal-title":"Immunol Res"},{"key":"ref291","first-page":"134","article-title":"la Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots","author":"Marca","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clinbiochem.2007.11.007","article-title":"Novel mutations of NP in two patients with purine nucleoside phosphorylase deficiency","author":"Parvaneh","year":"2008","journal-title":"Clin Biochem"},{"key":"ref281","first-page":"201","article-title":"la The inclusion of ADA - SCID in expanded newborn screening by tandem mass spectrometry","author":"Marca","year":"2014","journal-title":"Pharm Anal"},{"key":"ref211","doi-asserted-by":"crossref","DOI":"10.1080\/15257770.2011.630852","article-title":"nucleoside phosphorylase deficiency a mutation update","volume":"30","author":"Walker","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref301","first-page":"2015","article-title":"la Expanded newborn screening by mass spectrometry new tests future perspectives","author":"Ombrone","journal-title":"Mass Spectrom Rev"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/MOP.0b013e32834cb9b0","article-title":"Puck Neonatal for Combined Immunodeficiency","volume":"23","author":"Severe","year":"2011","journal-title":"Screening Curr Opin Pediatr"},{"key":"ref241","first-page":"480","article-title":"Combined immune deficiencies due to purine enzyme defects In ER HD JA editors Immunologic disorders in infants and children th ed Philadelphia PA","author":"Hershfield","year":"2004"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/MOP.0b013e32834cb9b0","article-title":"Puck Neonatal for Combined Immunodeficiency","volume":"23","author":"Severe","year":"2011","journal-title":"Screening Curr Opin Pediatr"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1016\/S0031-3955(05)70270-4","article-title":"immunodeficiencies","author":"Elder","year":"2000","journal-title":"cell Pediatr Clin Am"},{"key":"ref121","first-page":"201","article-title":"la The inclusion of ADA - SCID in expanded newborn screening by tandem mass spectrometry","author":"Marca","year":"2014","journal-title":"Pharm Anal"},{"key":"ref151","first-page":"45","article-title":"International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use ICH harmonized tripartite guideline : Guideline for Good Clinical","volume":"47","year":"2001","journal-title":"Practice J Postgrad Med"},{"key":"ref181","doi-asserted-by":"crossref","DOI":"10.1172\/JCI109058","article-title":"Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency","author":"Cohen","year":"1978","journal-title":"J Clin Invest"},{"key":"ref131","first-page":"134","article-title":"la Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots","author":"Marca","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"ref61","first-page":"125","article-title":"Primary immunodeficiencies","author":"Notarangelo","year":"2010","journal-title":"J Allergy Clin Immunol"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0436\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T19:49:45Z","timestamp":1619034585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0436\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":30,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1515\/cclm-2015-0436","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,1]]}}}